CHRISTINA HYLAND: Open Payments
NPI 1013489731 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 41 payments from 12 companies in 2025. Trend: 2023 $1,076 · 2024 $1,066 · 2025 $937
Food & beverage: $937
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $147 |
| HEARTFLOW, INC. | 5 | $143 |
| Novo Nordisk Inc | 5 | $133 |
| PFIZER INC. | 7 | $131 |
| Novartis Pharmaceuticals Corporation | 7 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| ABIOMED | 1 | $38 |
| Impulse Dynamics (USA) Inc. | 1 | $33 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $27 |
Products named: ELIQUIS, JARDIANCE, FFRct, LEQVIO, Wegovy, Kerendia, Optimizer, Ozempic.
Industry payments across PA — which companies pay providers there.
